Delforge, M. (., Shah, N. (., San-Miguel, J. (. F., Braverman, J. (., Dhanda, D. (. S., Shi, L. (., . . . Munshi, N. (. C. (2022). Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma.
Citación estilo ChicagoDelforge, M. (Michel)|||/items/f642fb6d-d632-430b-9601-260fd0bf5b45, et al. Health-related Quality of Life With Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma. 2022.
Cita MLADelforge, M. (Michel)|||/items/f642fb6d-d632-430b-9601-260fd0bf5b45, et al. Health-related Quality of Life With Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma. 2022.
Precaución: Estas citas no son 100% exactas.